{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:26:27Z","timestamp":1790724387867,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118629","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:46:43Z","timestamp":1760568403000},"page":"118629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effect of colchicine in heart failure patients with metabolic syndrome: Focus on inflammatory mechanisms"],"prefix":"10.1016","volume":"192","author":[{"given":"Nan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118629_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1906","article-title":"A concise history of gout and hyperuricemia and their treatment","volume":"8","author":"Nuki","year":"2006","journal-title":"Arthritis Res Ther."},{"issue":"6","key":"10.1016\/j.biopha.2025.118629_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.biopha.2025.118629_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ejhf.2493","article-title":"Cardiac remodelling - part 1: from cells and tissues to circulating biomarkers. A review from the study group on biomarkers of the heart failure association of the european society of cardiology","volume":"24","author":"Gonz\u00e1lez","year":"2022","journal-title":"Eur. J. Heart Fail"},{"issue":"10","key":"10.1016\/j.biopha.2025.118629_bib4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/hrt.2006.089011","article-title":"Metabolic syndrome and risk for heart failure in middle-aged men","volume":"92","author":"Ingelsson","year":"2006","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.biopha.2025.118629_bib5","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American heart association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2025.118629_bib6","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1253\/circj.CJ-10-0677","article-title":"Prevalence and clinical implication of metabolic syndrome in chronic heart failure","volume":"74","author":"Miura","year":"2010","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ejhf.2742","article-title":"Inflammation across universal definition of heart failure stages: the CASABLANCA study","volume":"25","author":"Mohebi","year":"2023","journal-title":"Eur. J. Heart Fail"},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ejhf.2767","article-title":"Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure","volume":"25","author":"Michou","year":"2023","journal-title":"Eur. J. Heart Fail"},{"issue":"11","key":"10.1016\/j.biopha.2025.118629_bib9","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/ejhf.3008","article-title":"Circulating neutrophil-related proteins associate with incident heart failure and cardiac dysfunction: the ARIC study","volume":"25","author":"Buckley","year":"2023","journal-title":"Eur. J. Heart Fail"},{"issue":"7","key":"10.1016\/j.biopha.2025.118629_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00011-013-0625-0","article-title":"Interleukin-1\u03b2 induces a reversible cardiomyopathy in the mouse","volume":"62","author":"Van Tassell","year":"2013","journal-title":"Inflamm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118629_bib11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.biopha.2025.118629_bib12","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.biopha.2025.118629_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur. J. Heart Fail"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib14","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1002\/ehf2.13539","article-title":"Neutrophils pro-inflammatory and anti-inflammatory cytokine release in patients with heart failure and reduced ejection fraction","volume":"8","author":"Chaar","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.biopha.2025.118629_bib15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000055318.09997.1F","article-title":"Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes","volume":"107","author":"Suematsu","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail Rev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118629_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2025.118629_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2459\/JCM.0000000000000974","article-title":"Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study","volume":"21","author":"Pugliese","year":"2020","journal-title":"J. Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"10.1016\/j.biopha.2025.118629_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"Van Tassell","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2025.118629_bib20","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","article-title":"Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study","volume":"111","author":"Abbate","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118629_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)","volume":"10","author":"Van Tassell","year":"2017","journal-title":"Circ. Heart Fail"},{"issue":"10","key":"10.1016\/j.biopha.2025.118629_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-Inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/FJC.0000000000000591","article-title":"Effect of Interleukin-1 blockade on left ventricular systolic performance and work: a post hoc pooled analysis of 2 clinical trials","volume":"72","author":"Buckley","year":"2018","journal-title":"J. Cardiovasc Pharm."},{"issue":"13","key":"10.1016\/j.biopha.2025.118629_bib24","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biopha.2025.118629_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther. Adv. Cardiovasc Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118629_bib26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1200\/JCO.2017.75.7526","article-title":"Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial","volume":"36","author":"Dieli-Conwright","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/jir.2013.0078","article-title":"IL-6 and TNF-\u03b1 induced obesity-related inflammatory response through transcriptional regulation of miR-146b","volume":"34","author":"Shi","year":"2014","journal-title":"J. Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijms16010378","article-title":"Oxidative stress in obesity: a critical component in human diseases","volume":"16","author":"Marseglia","year":"2014","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib29","first-page":"74","article-title":"Clinical significance of serum IL-6 and TNF-\u03b1 levels in patients with metabolic syndrome","volume":"6","author":"Mohammadi","year":"2017","journal-title":"Rep. Biochem Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5937\/jomb0-24652","article-title":"The role of oxidative stress in the development of obesity and obesity-related metabolic disorders","volume":"40","author":"\u010colak","year":"2021","journal-title":"J. Med. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib31","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/ijms12053117","article-title":"Inflammation, oxidative stress, and obesity","volume":"12","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2011","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118629_bib32","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.biopha.2025.118629_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14715\/cmb\/2023.69.15.46","article-title":"Influence of IL-10, IL-6 and TNF-\u03b1 gene polymorphism on obesity","volume":"69","author":"Hasan Azeez","year":"2023","journal-title":"Cell Mol Biol (Noisylegrand)"},{"issue":"10","key":"10.1016\/j.biopha.2025.118629_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108595","article-title":"NOD-like Receptors-Emerging links to obesity and associated morbidities","volume":"24","author":"Bauer","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s10020-024-00894-9","article-title":"Branched-chain amino acids supplementation induces insulin resistance and pro-inflammatory macrophage polarization via INFGR1\/JAK1\/STAT1 signal pathway","volume":"30","author":"Huang","year":"2024","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118629_bib36","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/ijerph110403586","article-title":"Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention","volume":"11","author":"Lukic","year":"2014","journal-title":"Int J. Environ. Res Public Health"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"7081","key":"10.1016\/j.biopha.2025.118629_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"9109","key":"10.1016\/j.biopha.2025.118629_bib40","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(05)79420-4","article-title":"Colchicine in pyoderma gangrenosum","volume":"351","author":"Rampal","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","article-title":"Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action","volume":"163","author":"Marques-da-Silva","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118629_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175126","article-title":"Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction","volume":"929","author":"Shen","year":"2022","journal-title":"Eur. J. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2025.118629_bib43","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1253\/circj.CJ-16-0949","article-title":"Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction","volume":"81","author":"Fujisue","year":"2017","journal-title":"Circ. J."},{"issue":"6","key":"10.1016\/j.biopha.2025.118629_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006195","article-title":"Colchicine depolymerizes microtubules, increases Junctophilin-2, and improves right ventricular function in experimental pulmonary arterial hypertension","volume":"6","author":"Prins","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"45","key":"10.1016\/j.biopha.2025.118629_bib46","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1093\/eurheartj\/ehae538","article-title":"Colchicine in acutely decompensated heart failure: the COLICA trial","volume":"45","author":"Pascual-Figal","year":"2024","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002360","article-title":"Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial","volume":"10","author":"Shchendrygina","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.biopha.2025.118629_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111677","article-title":"Colchicine stimulates browning via antagonism of GABA receptor b and agonism of \u03b23-adrenergic receptor in 3T3-L1 White adipocytes","volume":"552","author":"Choi","year":"2022","journal-title":"Mol. Cell Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12944-017-0573-8","article-title":"Per os colchicine administration in cholesterol fed rabbits: triglycerides lowering effects without affecting atherosclerosis progress","volume":"16","author":"Kaminiotis","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118629_bib50","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/dom.13702","article-title":"Effects of colchicine in adults with metabolic syndrome: a pilot randomized controlled trial","volume":"21","author":"Demidowich","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2025.118629_bib51","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jacl.2019.10.011","article-title":"Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: a secondary analysis of a randomized controlled trial","volume":"13","author":"Demidowich","year":"2019","journal-title":"J. Clin. Lipido"},{"issue":"8","key":"10.1016\/j.biopha.2025.118629_bib52","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41366-020-0598-3","article-title":"Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial","volume":"44","author":"Demidowich","year":"2020","journal-title":"Int J. Obes."},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/oby.23341","article-title":"Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome","volume":"30","author":"Levine","year":"2022","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/oby.23632","article-title":"Immunomodulatory effects of colchicine on peripheral blood mononuclear cell subpopulations in human obesity: data from a randomized controlled trial","volume":"31","author":"Patel","year":"2023","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.biopha.2025.118629_bib55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.12938\/bmfh.2023-001","article-title":"Colchicine effects on the gut microbiome in adults with metabolic syndrome","volume":"42","author":"Kisimba","year":"2023","journal-title":"Biosci. Micro Food Health"},{"issue":"18","key":"10.1016\/j.biopha.2025.118629_bib56","first-page":"e895","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation 2022"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2018.05.038","article-title":"Mechanical unloading in heart failure","volume":"72","author":"Uriel","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7752","key":"10.1016\/j.biopha.2025.118629_bib58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2025.118629_bib59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118629_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ. Heart Fail"},{"issue":"9","key":"10.1016\/j.biopha.2025.118629_bib61","first-page":"e9","article-title":"AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart Association\/American college of cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation 2023"},{"issue":"11","key":"10.1016\/j.biopha.2025.118629_bib62","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118629_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11886-024-02026-5","article-title":"Update on the role of colchicine in cardiovascular disease","volume":"26","author":"Banco","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"issue":"16","key":"10.1016\/j.biopha.2025.118629_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Kofler","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118629_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40256-024-00689-7","article-title":"Efficacy of colchicine for prevention of stroke and adverse cardiovascular events: a Meta-analysis of 16 randomized controlled trials","volume":"25","author":"Jaiswal","year":"2025","journal-title":"Am. J. Cardiovasc Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib66","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/M23-2788","article-title":"Newer pharmacologic treatments in adults with type 2 diabetes: a clinical guideline from the American college of physicians","volume":"177","author":"Qaseem","year":"2024","journal-title":"Ann. Intern Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.118629_bib67","doi-asserted-by":"crossref","DOI":"10.7326\/J24-0026","article-title":"In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo","volume":"177","author":"Bates","year":"2024","journal-title":"Ann. Intern Med"},{"issue":"6","key":"10.1016\/j.biopha.2025.118629_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19063395","article-title":"Association between clinical use of colchicine and risk of type 2 diabetes mellitus among gouty patients: a nationwide cohort study","volume":"19","author":"Chu","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2025.118629_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc23-1825","article-title":"Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"47","author":"Roubille","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2025.118629_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2016.04.039","article-title":"Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation","volume":"92","author":"Demidowich","year":"2016","journal-title":"Med Hypotheses"},{"issue":"7","key":"10.1016\/j.biopha.2025.118629_bib71","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/bcp.15688","article-title":"Colchicine enhances \u03b2 adrenoceptor-mediated vasodilation in men with essential hypertension","volume":"89","author":"Ehlers","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118629_bib72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2022.03.114","article-title":"Colchicine prevents ventricular arrhythmias vulnerability in diet-induced obesity rats","volume":"610","author":"Lv","year":"2022","journal-title":"Biochem. Biophys. Res Commun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:37:28Z","timestamp":1775781448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":72,"alternative-id":["S0753332225008236"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118629","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of colchicine in heart failure patients with metabolic syndrome: Focus on inflammatory mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118629"}}